Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Commercial Officer
-
Stock Symbol
-
RIGL on Nasdaq
David A. Santos - trading volume in the past year for Rigel Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
349K |
$398K |
$1.14 |
Feb 5, 2024 |
Direct |
|
|
| Employee Stock Option (right to buy) |
78.5K |
|
|
Feb 28, 2024 |
Direct |
Common Stock |
|
| Employee Stock Option (right to buy) |
8K |
|
|
Nov 25, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.